Atrial fibrillation and flutter as global drivers of heart failure: Burden and longitudinal trends over three decades
- PMID: 40511537
- DOI: 10.1002/ehf2.15344
Atrial fibrillation and flutter as global drivers of heart failure: Burden and longitudinal trends over three decades
Abstract
Aims: The study aims to comprehensively evaluate the global burden of heart failure attributable to atrial fibrillation (AF) and atrial flutter (AFL) from 1990 to 2021.
Methods: Using data from the Global Burden of Disease Study 2021, we estimated the prevalence and years lived with disability (YLDs) of heart failure attributable to AF/AFL across 204 countries and territories. Estimates were stratified by age, sex and socio-demographic index (SDI). Age-standardized rates per 100 000 population were calculated, and percentage changes between 1990 and 2021 were analysed to assess temporal trends.
Results: In 2021, AF/AFL were responsible for an estimated 714 137.5 [95% uncertainty interval (UI) 520 543.5 to 940 900.6] heart failure cases and 63 942.8 (95% UI 39 057.9 to 96 196.5) YLDs globally. The age-standardized prevalence and YLD rates were 8.85 (95% UI 6.38 to 11.63) and 0.79 (95% UI 0.49 to 1.19) per 100 000 population, respectively. Between 1990 and 2021, global absolute numbers of heart failure cases and YLDs attributable to AF/AFL increased by 339.3% (95% UI 292.7 to 387.0) and 337.5% (95% UI 290.1 to 387.0), respectively. Age-standardized prevalence and YLD rates increased by 65.2% (95% UI 47.7 to 83.8) and 65.4% (95% UI 46.6 to 83.5), respectively. The burden progressively increased with age, peaking among individuals aged ≥95 years. Females experienced a higher burden than males from age 55 years onward, with the greatest disparity observed in the 85-89 years age group. High SDI regions, such as Australasia and Western Europe, exhibited the highest prevalence and YLD rates.
Conclusions: The global burden of heart failure attributable to AF/AFL increased substantially from 1990 to 2021, disproportionately affecting older adults, females aged 55 years and above and populations in high SDI regions. These findings highlight the urgent need for targeted interventions and resource allocation to address the growing challenges, particularly for vulnerable groups.
Keywords: atrial fibrillation and flutter; epidemiology; heart failure; years lived with disability.
© 2025 The Author(s). ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
Similar articles
-
Global burden of atrial fibrillation/atrial flutter and its attributable risk factors from 1990 to 2019.Europace. 2023 Mar 30;25(3):793-803. doi: 10.1093/europace/euac237. Europace. 2023. PMID: 36603845 Free PMC article.
-
Global burden of atrial fibrillation/atrial flutter and its attributable risk factors from 1990 to 2021.Europace. 2024 Jul 2;26(7):euae195. doi: 10.1093/europace/euae195. Europace. 2024. PMID: 38984719 Free PMC article.
-
Differences in global, regional, and national time trends in disability-adjusted life years for atrial fibrillation and flutter, 1990-2019: an age-period-cohort analysis from the 2019 global burden of disease study.Front Cardiovasc Med. 2024 Aug 29;11:1401722. doi: 10.3389/fcvm.2024.1401722. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39267808 Free PMC article.
-
Global, regional, and national burden of heart failure associated with atrial fibrillation.BMC Cardiovasc Disord. 2023 Jul 11;23(1):345. doi: 10.1186/s12872-023-03375-9. BMC Cardiovasc Disord. 2023. PMID: 37430216 Free PMC article.
-
Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.Lancet Psychiatry. 2022 Feb;9(2):137-150. doi: 10.1016/S2215-0366(21)00395-3. Epub 2022 Jan 10. Lancet Psychiatry. 2022. PMID: 35026139 Free PMC article.
Cited by
-
Unraveling the role of gut microbiota on the formation of nephrolithiasis: insights from integrated analysis of GWAS, single-cell transcriptomics, bulk RNA sequencing and network Pharmacology.Urolithiasis. 2025 Jul 15;53(1):138. doi: 10.1007/s00240-025-01809-x. Urolithiasis. 2025. PMID: 40664942 Free PMC article.
-
Gut microbiota's role in heart failure.Heart Fail Rev. 2025 Jul 9. doi: 10.1007/s10741-025-10543-w. Online ahead of print. Heart Fail Rev. 2025. PMID: 40629225 Review.
References
-
- Ngo LTH, Peng Y, Denman R, Yang I, Ranasinghe I. Long‐term outcomes after hospitalization for atrial fibrillation or flutter. Eur Heart J 2024;45:2133‐2141. doi:10.1093/eurheartj/ehae204
-
- Ko D, Chung MK, Evans PT, Benjamin EJ, Helm RH. Atrial fibrillation: a review. JAMA 2024; doi:10.1001/jama.2024.22451
-
- Verhaert DVM, Brunner‐La Rocca HP, van Veldhuisen DJ, Vernooy K. The bidirectional interaction between atrial fibrillation and heart failure: consequences for the management of both diseases. Europace 2021;23:ii40‐ii45. doi:10.1093/europace/euaa368
-
- Manolis AS, Manolis TA, Manolis AA, Melita H. Atrial fibrillation‐induced tachycardiomyopathy and heart failure: an underappreciated and elusive condition. Heart Fail Rev 2022;27:2119‐2135. doi:10.1007/s10741‐022‐10221‐1
-
- Diamant MJ, Andrade JG, Virani SA, Jhund PS, Petrie MC, Hawkins NM. Heart failure and atrial flutter: a systematic review of current knowledge and practices. ESC Heart Fail 2021;8:4484‐4496. doi:10.1002/ehf2.13526
LinkOut - more resources
Full Text Sources